REVOLUTIONIZING DRUG DISCOVERY WITH AI: DIGITAL PHARMACY 4.0 FOR REGENERATIVE THERAPIES

Abstract

The advent of Digital Pharmacy 4.0, combined with artificial intelligence (AI), is poised to revolutionize drug discovery, particularly in regenerative medicine. This paper examines how AI-driven approaches can accelerate therapeutic development, enhance patient-centered care, and optimize clinical outcomes. Key areas of focus include predictive modeling for regenerative compounds, AI-assisted screening of bioactive molecules, integration of multi-omics data, and digital workflow transformation within pharmacy operations. A conceptual framework is proposed to integrate AI across discovery, development, and clinical implementation, highlighting operational, technological, and patient-centered considerations.